logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jamunarani Veeraraghavan

baylor college of medicine
H指数:24
被引数:2,230

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Detection of heterogeneous resistance mechanisms to tyrosine kinase inhibitors from cell-free DNA

检测细胞游离DNA中酪氨酸激酶抑制剂异质性耐药机制

Cell Genomics
IF9
2025-09-090
OAAI
Heather A. Parsons; Conor Messer; Katheryn Santos; Jakob Weiss; David Merrell; Brian P. Danysh; Melissa E. Hughes; Gregory J. Kirkner; Ashka Patel; Julian Hess; Kerry Sendrick; Chip Stewart; Elizabeth Grant; Kristy Schlueter-Kuck; Albert Grinshpun; Nikhil Wagle; Jamunarani Veeraraghavan; Jose Pablo Leone; Rachel A. Freedman; Otto Metzger; Rachel Schiff; Eric P. Winer; Sara M. Tolaney; Mothaffar Rimawi; Ian E. Krop; Gad Getz; Nancy U. Lin
High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer
CELL REPORTS
IF6.9
2023-08-014
OA
Fu, Xiaoyong; Pereira, Resel; Liu, Chia -Chia; De Angelis, Carmine; Shea, Martin J.; Nanda, Sarmistha; Qin, Lanfang; Mitchell, Tamika; Cataldo, Maria L.; Veeraraghavan, Jamunarani; Sethunath, Vidyalakshmi; Giuliano, Mario; Gutierrez, Carolina; Gyorffy, Balazs; Trivedi, Meghana, V; Cohen, Ofir; Wagle, Nikhil; Nardone, Agostina; Jeselsohn, Rinath; Rimawi, Mothaffar F.; Osborne, C. Kent; Schiff, Rachel
A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+Breast Cancer
CLINICAL CANCER RESEARCH
IF10.2
2023-05-174
OA
Veeraraghavan, Jamunarani; Gutierrez, Carolina; De Angelis, Carmine; Davis, Robert; Wang, Tao; Pascual, Tomas; Selenica, Pier; Sanchez, Katherine; Nitta, Hiroaki; Kapadia, Monesh; Pavlick, Anne C.; Galvan, Patricia; Rexer, Brent; Forero-Torres, Andres; Nanda, Rita; Storniolo, Anna M.; Krop, Ian E.; Goetz, Matthew P.; Nangia, Julie R.; Wolff, Antonio C.; Weigelt, Britta; Reis-Filho, Jorge S.; Hilsenbeck, Susan G.; Prat, Aleix; Osborne, C. Kent; Schiff, Rachel; Rimawi, Mothaffar F.
Resistance to next generation tyrosine kinase inhibitors (TKIs) in HER2-positive breast cancer (BC): Role of HER and PIK3CA mutations and development of new treatment strategies and study models
CANCER RESEARCH
IF16.6
2022-02-150
PRE
Bose, Sreyashree; Mistry, Ragini; Liu, Chia Chia; Nanda, Sarmistha; Qin, Lanfang; Selenica, Pier; Gazzo, Andrea; Zhu, Yingjie; Mancini, Michael A.; Stossi, Fabio; Diala, Irmina; Eli, Lisa D.; Weigelt, Britta; Reis-Filho, Jorge S.; Rimawi, Mothaffar F.; Osborne, C. Kent; Schiff, Rachel; Veeraraghavan, Jamunarani
Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models
NPJ BREAST CANCER
IF7.6
2021-05-277
OAAI
Veeraraghavan, Jamunarani; Gutierrez, Carolina; Sethunath, Vidyalakshmi; Mehravaran, Sepideh; Giuliano, Mario; Shea, Martin J.; Mitchell, Tamika; Wang, Tao; Nanda, Sarmistha; Pereira, Resel; Davis, Robert; Goutsouliak, Kristina; Qin, Lanfang; De Angelis, Carmine; Diala, Irmina; Lalani, Alshad S.; Nagi, Chandandeep; Hilsenbeck, Susan G.; Rimawi, Mothaffar F.; Osborne, C. Kent; Schiff, Rachel
Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer

Nemo样激酶靶向治疗原发性和获得性内分泌耐药乳腺癌

CLINICAL CANCER RESEARCH
IF10.2
2021-02-047
OA
Wang, Xian; Veeraraghavan, Jamunarani; Liu, Chia-Chia; Cao, Xixi; Qin, Lanfang; Kim, Jin-Ah; Tan, Ying; Loo, Suet Kee; Hu, Yiheng; Lin, Ling; Lee, Sanghoon; Shea, Martin J.; Mitchell, Tamika; Li, Shunqiang; Ellis, Matthew J.; Hilsenbeck, Susan G.; Schiff, Rachel; Wang, Xiao-Song
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis
CANCER TREATMENT REVIEWS
IF10.5
2020-03-0199
OAAI
Schettini, Francesco; Pascual, Tomas; Conte, Benedetta; Chic, Nuria; Braso-Maristany, Fara; Galvan, Patricia; Martinez, Olga; Adamo, Barbara; Vidal, Maria; Munoz, Montserrat; Fernandez-Martinez, Aranzazu; Rognoni, Carla; Griguolo, Gaia; Guarneri, Valentina; Conte, Pier Franco; Locci, Mariavittoria; Brase, Jan C.; Gonzalez-Farre, Blanca; Villagrasa, Patricia; De Placido, Sabino; Schiff, Rachel; Veeraraghavan, Jamunarani; Rimawi, Mothaffar F.; Osborne, C. Kent; Pernas, Sonia; Perou, Charles M.; Carey, Lisa A.; Prat, Aleix
High levels of interferon-response gene signatures are associated with de novo and acquired resistance to CDK4/6 inhibitors in ER plus breast cancer
CANCER RESEARCH
IF16.6
2020-02-154
PRE
De Angelis, Carmine; Fu, Xiaoyong; Cataldo, Maria Letizia; Nardone, Agostina; Jansen, Valerie M.; Veeraraghavan, Jamunarani; Nanda, Sarmistha; Qin, Lanfang; Sethunath, Vidyalakshmi; Pereira, Resel; Benelli, Matteo; Migliaccio, Ilenia; Malorni, Luca; Donaldson, Joshua; Selenica, Pier; Brown, David N.; Weigelt, Britta; Reis-Filho, Jorge S.; Park, Ben H.; Hurvitz, Sara A.; Slamon, Dennis J.; Rimawi, Mothaffar F.; Jeselsohn, Rinath; Osborne, Kent; Schiff, Rachel
Integrative cistromic/transcriptomic profiling identifies a high FOXA1/ER-activated pro-metastatic secretome in endocrine-resistant breast cancer
CANCER RESEARCH
IF16.6
2020-02-150
PRE
Fu, Xiaoyong; Pereira, Resel; De Angelis, Carmine; Nanda, Sarmistha; Qin, Lanfang; Shea, Martin J.; Mitchell, Tamika; Veeraraghavan, Jamunarani; Sethunath, Vidyalakshmi; Gutierrez, Carolina; Gyorffy, Balazs; Cohen, Ofir; Wagle, Nikhil; Nardone, Agostina; Jeselsohn, Rinath; Brown, Myles; Rimawi, Mothaffar F.; Osborne, C. Kent; Schiff, Rachel
TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer
CLINICAL CANCER RESEARCH
IF10.2
2020-02-1435
OAAI
Rimawi, Mothaffar F.; Niravath, Polly; Wang, Tao; Rexer, Brent N.; Forero, Andres; Wolff, Antonio C.; Nanda, Rita; Storniolo, Anna M.; Krop, Ian; Goetz, Matthew P.; Nangia, Julie R.; Jiralerspong, Sao; Pavlick, Anne; Veeraraghavan, Jamunarani; De Angelis, Carmine; Gutierrez, Carolina; Schiff, Rachel; Hilsenbeck, Susan G.; Osborne, C. Kent

研究方向

暂未获取到该数据
R
Rachel Schiff
H 指数:84论文数:609被引数:2.4万
M
Mothaffar F. Rimawi
H 指数:52论文数:509被引数:1.0万
L
Lanfang Qin
H 指数:12论文数:110被引数:1,173
S
Sarmistha Nanda
H 指数:13论文数:108被引数:1,262
C
Carmine De Angelis
H 指数:39论文数:375被引数:6,628
C
C. Kent Osborne
H 指数:95论文数:399被引数:4.2万
V
Vidyalakshmi Sethunath
H 指数:12论文数:52被引数:1,118
J
Jorge S. Reis‐Filho
H 指数:153论文数:1,521被引数:9.5万
X
Xiaoyong Fu
H 指数:37论文数:228被引数:5,476
S
Susan G. Hilsenbeck
H 指数:103论文数:1,123被引数:3.4万